Create SD Holdings Co., Ltd.
Create SD Holdings Co., Ltd. 3148.T Peers
See (3148.T) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 3148.T | $3,215.00 | +0.94% | 207.70B | 14.63 | $219.68 | +2.21% |
| 3088.T | $2,889.50 | -2.84% | 1.17T | 23.21 | $124.49 | +1.52% |
| 3349.T | $8,680.00 | -1.89% | 687.95B | 23.38 | $371.29 | +0.72% |
| 9989.T | $4,799.00 | -1.38% | 561.33B | 18.60 | $257.98 | +2.71% |
| 3391.T | $11,235.00 | -1.27% | 546.78B | 33.36 | $336.74 | +3.56% |
| 7649.T | $3,019.00 | -3.14% | 546.34B | 21.25 | $142.06 | +1.16% |
| 3141.T | $2,475.00 | -1.51% | 513.77B | 34.27 | $72.23 | +1.45% |
| 3549.T | $3,605.00 | +0.75% | 370.41B | 20.49 | $175.95 | +0.35% |
| 9627.T | $5,455.00 | -0.76% | 191.25B | 19.06 | $286.16 | +1.47% |
| 9267.T | $3,585.00 | -1.10% | 108.97B | 16.18 | $221.60 | +0.36% |
Stock Comparison
3148.T vs 3088.T Comparison
3148.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3148.T stands at 207.70B. In comparison, 3088.T has a market cap of 1.17T. Regarding current trading prices, 3148.T is priced at $3,215.00, while 3088.T trades at $2,889.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3148.T currently has a P/E ratio of 14.63, whereas 3088.T's P/E ratio is 23.21. In terms of profitability, 3148.T's ROE is +0.11%, compared to 3088.T's ROE of +0.10%. Regarding short-term risk, 3148.T is less volatile compared to 3088.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3148.T.
3148.T vs 3349.T Comparison
3148.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3148.T stands at 207.70B. In comparison, 3349.T has a market cap of 687.95B. Regarding current trading prices, 3148.T is priced at $3,215.00, while 3349.T trades at $8,680.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3148.T currently has a P/E ratio of 14.63, whereas 3349.T's P/E ratio is 23.38. In terms of profitability, 3148.T's ROE is +0.11%, compared to 3349.T's ROE of +0.12%. Regarding short-term risk, 3148.T is less volatile compared to 3349.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3148.T.
3148.T vs 9989.T Comparison
3148.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3148.T stands at 207.70B. In comparison, 9989.T has a market cap of 561.33B. Regarding current trading prices, 3148.T is priced at $3,215.00, while 9989.T trades at $4,799.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3148.T currently has a P/E ratio of 14.63, whereas 9989.T's P/E ratio is 18.60. In terms of profitability, 3148.T's ROE is +0.11%, compared to 9989.T's ROE of +0.12%. Regarding short-term risk, 3148.T is more volatile compared to 9989.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3148.T.
3148.T vs 3391.T Comparison
3148.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3148.T stands at 207.70B. In comparison, 3391.T has a market cap of 546.78B. Regarding current trading prices, 3148.T is priced at $3,215.00, while 3391.T trades at $11,235.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3148.T currently has a P/E ratio of 14.63, whereas 3391.T's P/E ratio is 33.36. In terms of profitability, 3148.T's ROE is +0.11%, compared to 3391.T's ROE of +0.06%. Regarding short-term risk, 3148.T is more volatile compared to 3391.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3148.T.
3148.T vs 7649.T Comparison
3148.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3148.T stands at 207.70B. In comparison, 7649.T has a market cap of 546.34B. Regarding current trading prices, 3148.T is priced at $3,215.00, while 7649.T trades at $3,019.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3148.T currently has a P/E ratio of 14.63, whereas 7649.T's P/E ratio is 21.25. In terms of profitability, 3148.T's ROE is +0.11%, compared to 7649.T's ROE of +0.11%. Regarding short-term risk, 3148.T is less volatile compared to 7649.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3148.T.
3148.T vs 3141.T Comparison
3148.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3148.T stands at 207.70B. In comparison, 3141.T has a market cap of 513.77B. Regarding current trading prices, 3148.T is priced at $3,215.00, while 3141.T trades at $2,475.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3148.T currently has a P/E ratio of 14.63, whereas 3141.T's P/E ratio is 34.27. In terms of profitability, 3148.T's ROE is +0.11%, compared to 3141.T's ROE of +0.06%. Regarding short-term risk, 3148.T is more volatile compared to 3141.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3148.T.
3148.T vs 3549.T Comparison
3148.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3148.T stands at 207.70B. In comparison, 3549.T has a market cap of 370.41B. Regarding current trading prices, 3148.T is priced at $3,215.00, while 3549.T trades at $3,605.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3148.T currently has a P/E ratio of 14.63, whereas 3549.T's P/E ratio is 20.49. In terms of profitability, 3148.T's ROE is +0.11%, compared to 3549.T's ROE of +0.13%. Regarding short-term risk, 3148.T is more volatile compared to 3549.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3148.T.
3148.T vs 9627.T Comparison
3148.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3148.T stands at 207.70B. In comparison, 9627.T has a market cap of 191.25B. Regarding current trading prices, 3148.T is priced at $3,215.00, while 9627.T trades at $5,455.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3148.T currently has a P/E ratio of 14.63, whereas 9627.T's P/E ratio is 19.06. In terms of profitability, 3148.T's ROE is +0.11%, compared to 9627.T's ROE of +0.07%. Regarding short-term risk, 3148.T is more volatile compared to 9627.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3148.T.
3148.T vs 9267.T Comparison
3148.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3148.T stands at 207.70B. In comparison, 9267.T has a market cap of 108.97B. Regarding current trading prices, 3148.T is priced at $3,215.00, while 9267.T trades at $3,585.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3148.T currently has a P/E ratio of 14.63, whereas 9267.T's P/E ratio is 16.18. In terms of profitability, 3148.T's ROE is +0.11%, compared to 9267.T's ROE of +0.14%. Regarding short-term risk, 3148.T is more volatile compared to 9267.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3148.T.
3148.T vs 3341.T Comparison
3148.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3148.T stands at 207.70B. In comparison, 3341.T has a market cap of 94.41B. Regarding current trading prices, 3148.T is priced at $3,215.00, while 3341.T trades at $3,160.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3148.T currently has a P/E ratio of 14.63, whereas 3341.T's P/E ratio is 67.72. In terms of profitability, 3148.T's ROE is +0.11%, compared to 3341.T's ROE of +0.02%. Regarding short-term risk, 3148.T is less volatile compared to 3341.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3148.T.
3148.T vs 3034.T Comparison
3148.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3148.T stands at 207.70B. In comparison, 3034.T has a market cap of 70.71B. Regarding current trading prices, 3148.T is priced at $3,215.00, while 3034.T trades at $1,883.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3148.T currently has a P/E ratio of 14.63, whereas 3034.T's P/E ratio is 16.70. In terms of profitability, 3148.T's ROE is +0.11%, compared to 3034.T's ROE of +0.09%. Regarding short-term risk, 3148.T is less volatile compared to 3034.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3148.T.
3148.T vs 2664.T Comparison
3148.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3148.T stands at 207.70B. In comparison, 2664.T has a market cap of 64.01B. Regarding current trading prices, 3148.T is priced at $3,215.00, while 2664.T trades at $2,866.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3148.T currently has a P/E ratio of 14.63, whereas 2664.T's P/E ratio is 14.63. In terms of profitability, 3148.T's ROE is +0.11%, compared to 2664.T's ROE of +0.04%. Regarding short-term risk, 3148.T is more volatile compared to 2664.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3148.T.
3148.T vs 219A.T Comparison
3148.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3148.T stands at 207.70B. In comparison, 219A.T has a market cap of 53.36B. Regarding current trading prices, 3148.T is priced at $3,215.00, while 219A.T trades at $2,370.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3148.T currently has a P/E ratio of 14.63, whereas 219A.T's P/E ratio is -47.97. In terms of profitability, 3148.T's ROE is +0.11%, compared to 219A.T's ROE of -0.10%. Regarding short-term risk, 3148.T is less volatile compared to 219A.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3148.T.
3148.T vs 4931.T Comparison
3148.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3148.T stands at 207.70B. In comparison, 4931.T has a market cap of 51.58B. Regarding current trading prices, 3148.T is priced at $3,215.00, while 4931.T trades at $2,442.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3148.T currently has a P/E ratio of 14.63, whereas 4931.T's P/E ratio is 18.89. In terms of profitability, 3148.T's ROE is +0.11%, compared to 4931.T's ROE of +0.14%. Regarding short-term risk, 3148.T is less volatile compared to 4931.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3148.T.
3148.T vs 7679.T Comparison
3148.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3148.T stands at 207.70B. In comparison, 7679.T has a market cap of 39.13B. Regarding current trading prices, 3148.T is priced at $3,215.00, while 7679.T trades at $1,997.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3148.T currently has a P/E ratio of 14.63, whereas 7679.T's P/E ratio is 10.21. In terms of profitability, 3148.T's ROE is +0.11%, compared to 7679.T's ROE of +0.12%. Regarding short-term risk, 3148.T is more volatile compared to 7679.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3148.T.
3148.T vs 8095.T Comparison
3148.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3148.T stands at 207.70B. In comparison, 8095.T has a market cap of 19.42B. Regarding current trading prices, 3148.T is priced at $3,215.00, while 8095.T trades at $481.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3148.T currently has a P/E ratio of 14.63, whereas 8095.T's P/E ratio is -7.61. In terms of profitability, 3148.T's ROE is +0.11%, compared to 8095.T's ROE of -0.08%. Regarding short-term risk, 3148.T is more volatile compared to 8095.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3148.T.
3148.T vs 4350.T Comparison
3148.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3148.T stands at 207.70B. In comparison, 4350.T has a market cap of 13.12B. Regarding current trading prices, 3148.T is priced at $3,215.00, while 4350.T trades at $449.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3148.T currently has a P/E ratio of 14.63, whereas 4350.T's P/E ratio is 8.13. In terms of profitability, 3148.T's ROE is +0.11%, compared to 4350.T's ROE of +0.10%. Regarding short-term risk, 3148.T is less volatile compared to 4350.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3148.T.
3148.T vs 3417.T Comparison
3148.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3148.T stands at 207.70B. In comparison, 3417.T has a market cap of 12.66B. Regarding current trading prices, 3148.T is priced at $3,215.00, while 3417.T trades at $928.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3148.T currently has a P/E ratio of 14.63, whereas 3417.T's P/E ratio is 6.81. In terms of profitability, 3148.T's ROE is +0.11%, compared to 3417.T's ROE of +0.08%. Regarding short-term risk, 3148.T is more volatile compared to 3417.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3148.T.
3148.T vs 3544.T Comparison
3148.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3148.T stands at 207.70B. In comparison, 3544.T has a market cap of 12.63B. Regarding current trading prices, 3148.T is priced at $3,215.00, while 3544.T trades at $918.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3148.T currently has a P/E ratio of 14.63, whereas 3544.T's P/E ratio is 20.76. In terms of profitability, 3148.T's ROE is +0.11%, compared to 3544.T's ROE of +0.07%. Regarding short-term risk, 3148.T is more volatile compared to 3544.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3148.T.
3148.T vs 4890.T Comparison
3148.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3148.T stands at 207.70B. In comparison, 4890.T has a market cap of 9.77B. Regarding current trading prices, 3148.T is priced at $3,215.00, while 4890.T trades at $381.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3148.T currently has a P/E ratio of 14.63, whereas 4890.T's P/E ratio is 24.31. In terms of profitability, 3148.T's ROE is +0.11%, compared to 4890.T's ROE of +0.29%. Regarding short-term risk, 3148.T is less volatile compared to 4890.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3148.T.
3148.T vs 2796.T Comparison
3148.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3148.T stands at 207.70B. In comparison, 2796.T has a market cap of 5.57B. Regarding current trading prices, 3148.T is priced at $3,215.00, while 2796.T trades at $490.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3148.T currently has a P/E ratio of 14.63, whereas 2796.T's P/E ratio is -6.83. In terms of profitability, 3148.T's ROE is +0.11%, compared to 2796.T's ROE of -0.11%. Regarding short-term risk, 3148.T is more volatile compared to 2796.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3148.T.